Cicada Innovations
VC Fund
Sydney, Australia
Cicada Innovations is a VC fund in Sydney focused on Health Care and Analytics. Cicada Innovations, formerly known as ATP Innovations, is Australia's leading business incubator. The combination of our track record and deep expertise helps our talented entrepreneurs to consistently achieve success.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries Cicada Innovations invests in
Health CareAnalyticsMedical DeviceBiotechnologyTransportation
Stages Cicada Innovations invests in
SeedSeries BConvertible NoteFunding RoundSeries A
Countries Cicada Innovations invests in
AustraliaUnited StatesUnited Kingdom
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arjan Goudsblom
|
|||
Ben Wright
|
|||
Dharmica Mistry
|
|||
Niamh Kyriacou
|
|||
Petra Andrén
|
|||
| See all 6 contacts → | |||
Investment Focus
Industry
- Health Care 7 (41%)
- Analytics 4 (24%)
- Medical Device 4 (24%)
- Biotechnology 3 (18%)
- Transportation 3 (18%)
Stage
- Seed 6 (35%)
- Series B 3 (18%)
- Convertible Note 3 (18%)
- Funding Round 2 (12%)
- Series A 1 (6%)
Country
- Australia 13 (76%)
- United States 3 (18%)
- United Kingdom 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Arjan Goudsblom
Head of Mentoring and Global Growth
|
Head of Mentoring and Global Growth | Total investments: 0 | Find email | |
|
Ben Wright
Chief Innovation Officer & Head of Investment
|
Chief Innovation Officer & Head of Investment | Total investments: 0 | Find email | |
|
Dharmica Mistry
Founder & Head of medtech
|
Founder & Head of medtech | Total investments: 0 | Find email | |
|
Niamh Kyriacou
Community & Events Manager
|
Community & Events Manager | Total investments: 0 | Find email | |
|
Petra Andrén
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Leo Cancer Care
|
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position. The company designs integrated imaging, patient positioning, and treatment systems that are compatible with fixed radiation beam platforms used in photon and particle therapy. Its technology focuses on supporting the radiotherapyworkflow from patient simulation through treatment while enabling multiple radiation therapy modalities. Leo Cancer Care also collaborates with healthcare providers, research institutions, and industry partners to evaluate and advance the clinical use of upright radiotherapy systems. In addition to developing treatment technologies, the company works on expanding access to radiotherapy through solutions that aim to improve workflow efficiency and compatibility with existing treatment infrastructure. | Series C / Jun 11, 2024 | |
Sonder
|
One app. One go-to. One support system.Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they reimagine how to care and support their people.With a clear purpose of breaking down barriers to help, providing the right support to people at the right time. Acknowledging that there are often multiplefactors at play, and wellbeing comprises of cultural, social, environmental and vocational factors, all which play a part in getting to the root cause of issues, and on a path to wellness.The heart of Sonder's solution is a technology-driven platform supported in real time by medical and mental health experts - experts that are available every minute of every day. Their mission is to get the right outcome across any wellbeing or safety issue.Trusted by major corporations, education providers and Government to enhance wellbeing across the world, Sonder is on a mission to create a better world, accepting differences and supportive of others. A world where it's OK to ask for help, for anything, at any time of the day or night.It takes humans to help other humans. That’s why Sonder combines a human first, tech supported approach. | $10.5M / Series B / Jan 25, 2024 | |
Calumino
|
Developed the "ultimate sensor". Mass-deployable thermal sensor + AI. Capturing unprecedented, privacy-protecting, human activity and safety data. Platform technology with vast benefits for IOT, smart buildings, smart devices, security, fire safety, energy, industrial, automotive, health care and other markets. | $10.3M / Series A / Sep 20, 2022 | |
Lleaf
|
Lleaf has created an innovative luminescent technology for greenhouses that harnesses the power of sunlight to improve crop yield by up to 40%, with virtually zero operational cost. | $3.5M / Convertible Note / Sep 13, 2022 | |
Loop Plus
|
Loop Plus is a remote rehabilitation platform that accesses sensor technology to translate care plans from the clinic into the home, creating a feedback loop with clinicians in patient's everyday lives. The first product is loop+ an activity tracker for wheelchair users that creates a positive feedback look with clinicians and carers tomonitor health risks in everyday life. For the first time, wheelchair users who either can’t feel their lower limbs or are non-verbal and unable to communicate their discomfort, have a way to visualize what’s going on with body. Remote monitoring supports the detection and intervention of pressure wounds, respiratory issues, and scoliosis. | Seed / Sep 21, 2021 | |
Prospection
|
Prospection is a Pioneer in healthcare data analytics. Using predictive analytics and machine learning with real world healthcare data to unearth insights that help research, develop and target better healthcare outcomes for patients. Founded out of Sydney’s Cicada Innovations in 2012, Prospection works with government, pharmaceutical companies andthe medical community across more than 90 therapy programs, including immuno-oncology, Diabetes, Respiratory, HIV and hepatitis, in Australia, Japan, Asia Pacific, UK and USA. | $33.1M / Series B / Sep 13, 2021 | |
Haemalogix
|
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.HaemaLogiX acquired the business and assets of Immune System Therapeutics Ltd and is embarking on a program of several inter-related projects that will validate antigen targets and products.Two novel drug targets - Kappa Myeloma Antigen(KMA) and Lambda Myeloma Antigen (LMA), have been identified on the surface of human blood cancer and autoimmune cells. These targets are highly specific to abnormal B-cells and have been identified in blood cancers such as multiple myeloma (MM), lymphoma and Waldenstroms macroglobulinemia.Our program will rationally review and pursue opportunities that will deliver a positive proof of the clinical and financial viability of our assets. These opportunities include:validation of antibodies and CAR-T cells;proof of concept for both Kappa and Lambda antigens; anda good understanding of their clinical utility in treating the selected patient populationsIn pursuing these projects we wish to deliver significant and risk mitigated medium term returns to our investors. | $7.4M / Venture - Series Unknown / Sep 08, 2021 | |
SDIP Innovations
|
SDIP Innovations is a platform that engages bioresorbable bone implants to mimic the natural bone remodeling to heal fractured bones. It is an implantable device that resorbs the body and encourages tissue regeneration. | Convertible Note / Apr 23, 2021 | |
FluroSat
|
Advanced agronomic analytics that use the power of ag data and science-based crop models for farm insights. | $3.2M / Jul 23, 2019 | |
Neuromersiv
|
Combining Virtual Reality, haptics and functional electrical stimulation, Neuromersiv is revolutionising brain rehabilitation therapy.Using a proprietary wearable device paired with a VR headset, Neuromersiv provides an engaging, immersive therapy experience in which patients perform gamified tasks ranging from picking up a toothbrush to climbingEverest! This unique approach increases dopamine activity in the brain, enhancing neuroplasticity, which is the brain’s ability to form new neural connections. Early trials of Neuromersiv technology have demonstrated 3x better outcomes as compared to traditional rehabilitation therapy resulting in faster independence and reduced care costs. | $34K / Convertible Note / Sep 01, 2018 | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Transportation Investors
27,893 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Device Investors
11,047 investors
SaaS VC Funds
61,208 investors
Health Care VC Funds
32,370 investors
Transportation VC Funds
21,585 investors
FAQ
What does Cicada Innovations invest in?
Cicada Innovations invests primarily in Health Care, Analytics and Medical Device startups, most often at Seed and Series B stage. Most of the 17 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cicada Innovations?
Public channels for Cicada Innovations include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cicada Innovations?
The team at Cicada Innovations includes Arjan Goudsblom (Head of Mentoring and Global Growth), Ben Wright (Chief Innovation Officer & Head of Investment) and Dharmica Mistry (Founder & Head of medtech), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
